Dr. Zhenzhen Xu, MD

Dr. Xu practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Xu's NPI, 1194229153, was assigned on March 22, 2018. Dr. Xu graduated from Yale School of Medicine in 2018. Dr. Xu's California license number on file is A167048.

Dr. Xu's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Xu's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Xu to 1 more clinical lab and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Xu practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Xu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Xu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Xu's licenses on file in 2 states: California and Texas.

Dmand AI lists congestive heart failure, non-surgical back problems and pancreatitis among the conditions Dr. Xu treats.

CMS data shows 154 Medicare services from Dr. Xu across 3 procedure codes in 2024, for 55 Medicare patients. Medicare paid $13,667 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 55 Medicare patients who saw Dr. Xu in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Xu's median patient age at 60, with 47% women.

In 2024, Dr. Xu wrote 112 Medicare Part D claims for 31 patients. 78% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $171 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Xu for performance year 2024, reported as part of a group. Dr. Xu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Xu, published from 2016 to 2018. The most frequent topics are Pressure Ulcer and Wound Healing. Dr. Xu has published most often in Ann Plast Surg. Dr. Xu's most frequent co-author is Andrew Bonwook Koo, MD.

Dr. Xu graduated from Yale School of Medicine in 2018.

Dr. Xu is in network with 15 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.